{"gene":"PER2","run_date":"2026-04-29T11:37:58","timeline":{"discoveries":[{"year":2005,"finding":"CKIε phosphorylates PER2, recruiting the ubiquitin E3 ligase adapter β-TrCP to a specific phosphodegron site, leading to PER2 ubiquitination and 26S proteasome-mediated degradation; CKIε inhibition slows PER2 degradation and lengthens circadian period in Rat-1 cells.","method":"Cell-based PER2 degradation assay, dominant-negative β-TrCP overexpression, proteasome inhibitors, CKIε inhibition, circadian period measurement in synchronized cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal biochemical and cell-based methods in single study; replicated by subsequent work","pmids":["15767683"],"is_preprint":false},{"year":2007,"finding":"Phosphorylation of PER2 at S662 by CKIδ stabilizes PER2 and increases Per2 transcription; the FASPS S662G mutation causes PER2 hypophosphorylation at this site and advanced sleep phase; CKIδ dosage modulates the S662 phenotype, demonstrating CKIδ regulates period through PER2 in vivo.","method":"Transgenic mice carrying human FASPS PER2 S662G mutation, in vitro CKI phosphorylation assay, behavioral circadian analysis, CKIδ dosage manipulation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro assay plus transgenic mouse model with human mutation; functional rescue experiments","pmids":["17218255"],"is_preprint":false},{"year":2008,"finding":"β-TrCP2 (as well as β-TrCP1) directly targets PER2 for degradation via a specific binding site (m2) on PER2; siRNA-mediated knockdown of β-TrCP1 and/or β-TrCP2 attenuates circadian oscillations in NIH3T3 cells.","method":"In vitro ubiquitin ligase assay, Luciferase-PER2 fusion stability assay, siRNA knockdown, real-time circadian reporter assay","journal":"Journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding site mapping plus functional cell-based assay with RNAi","pmids":["18782782"],"is_preprint":false},{"year":2006,"finding":"Protein phosphatase 1 (PP1) dephosphorylates CKI-phosphorylated PER2, stabilizing it against ubiquitin-proteasome degradation; PER2 co-immunoprecipitates with PP1c in HEK-293 cells, mouse liver, and mouse brain; dominant-negative PP1c or PP1 inhibitors accelerate PER2 degradation and shorten PER2 half-life.","method":"Co-immunoprecipitation, Xenopus egg extract degradation assay, dominant-negative PP1c overexpression, PP1 inhibitor treatment, pulse-chase half-life measurement","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including reconstituted dephosphorylation assay and in vivo tissue co-IP","pmids":["16813562"],"is_preprint":false},{"year":2018,"finding":"CK1δ/ε (including the CK1δ2 splice variant) serves as both the priming kinase and the downstream kinase for PER2; priming phosphorylation by CK1δ/ε initiates the phosphoswitch that stabilizes PER2 and lengthens circadian period; the CK1 C-terminal tail modulates period sensitivity to cellular signaling.","method":"Comprehensive biochemical and biophysical analysis of mPER2 priming phosphorylation in cells, mathematical phosphoswitch modeling, splice-variant comparison","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution plus mathematical modeling; multiple CK1 splice variants tested","pmids":["29784789"],"is_preprint":false},{"year":2020,"finding":"Phosphorylation of PER2 at Ser478 by CK1 creates a β-TrCP phosphodegron; PER2-S478A knock-in mice show longer circadian period, accumulation of PER2 protein in nucleus and cytoplasm of liver, increased nuclear PER1/CRY1/CRY2, and perturbed three-phase decay and temperature compensation of circadian period in fibroblasts.","method":"PER2-S478A knock-in mouse generation, behavioral circadian analysis, western blot, PER2::LUC bioluminescence in mouse embryonic fibroblasts","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo knock-in mouse with multiple molecular and behavioral readouts","pmids":["32354999"],"is_preprint":false},{"year":2020,"finding":"A conserved anion binding site in CK1 controls activation loop conformation and determines which sites on PER2 (stabilizing vs. destabilizing) are preferentially phosphorylated; period-altering CK1 mutations from humans to Drosophila differentially modulate this activation loop switch to elicit predictable changes in PER2 stability.","method":"Integrated experimental and computational studies, mutagenesis of CK1 anion binding site, measurement of PER2 phosphorylation and stability","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 — structural/mechanistic biochemistry with mutagenesis across multiple species orthologs","pmids":["32043967"],"is_preprint":false},{"year":2002,"finding":"PER2 activates transcription of BMAL1; CRY1, CRY2, and PER2 together upregulate BMAL1 expression while BMAL1-CLOCK heterodimers repress it, forming an interlocked feedback loop in the mammalian circadian clock.","method":"Promoter-reporter luciferase assay, genomic structure characterization of mBmal1","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — cell-based transcriptional assay; single lab but mechanistically clear","pmids":["11798163"],"is_preprint":false},{"year":2008,"finding":"PER2 physically interacts with BMAL1 and CLOCK (but not CRY1/CRY2 with CLOCK); CRY proteins interact with BMAL1 at different domains than PER2; together PER2 and CRY proteins inhibit BMAL1-CLOCK transcriptional activation.","method":"Mammalian two-hybrid system, co-immunoprecipitation","journal":"BMC molecular biology","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP and two-hybrid from single lab; replicated conceptually across field","pmids":["18430226"],"is_preprint":false},{"year":2012,"finding":"PML (promyelocytic leukemia protein) physically interacts with PER2 and promotes PER2 nuclear localization in SCN neurons; loss of PML shifts PER2 to a predominantly perinuclear/cytoplasmic distribution and disrupts clock gene rhythms; SIRT1 deacetylates PML at K487 to regulate PML control of PER2 nuclear localization.","method":"Co-immunoprecipitation, immunofluorescence localization, Pml-/- mouse analysis, SIRT1 deacetylation assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — direct interaction shown by co-IP, loss-of-function mouse with defined localization phenotype, PTM identified","pmids":["22274616"],"is_preprint":false},{"year":2022,"finding":"CRY proteins are required for PER2 nuclear localization in SCN neurons; in the absence of CRY, PER2 is predominantly cytoplasmic and more mobile (measured by FRAP); virally expressed CRY1 or CRY2 relocalized PER2 to the nucleus and initiated SCN circadian rhythms; the C-terminal tail of CRY1 is necessary for PER2 nuclear relocalization.","method":"Confocal imaging of PER2::Venus reporter mice, viral vector expression of CRY variants, FRAP, translational switching to control CRY1 abundance","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — live imaging with FRAP plus CRY domain mutagenesis in intact SCN tissue","pmids":["35046033"],"is_preprint":false},{"year":2017,"finding":"PER2 interacts with HIF-1α via co-immunoprecipitation and facilitates recruitment of HIF-1α to the hypoxia-response element (HRE) of the VEGF promoter; this requires that HIF-1α N803 is unhydroxylated; PER2 enhances HIF-1 transcriptional activity without changing HIF-1α protein or mRNA levels.","method":"Co-immunoprecipitation, chromatin immunoprecipitation/HRE binding assay, N803A point mutant of HIF-1α, deferoxamine treatment","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus functional ChIP-type assay; single lab with multiple orthogonal methods","pmids":["28963769"],"is_preprint":false},{"year":2017,"finding":"SIK3 promotes phosphorylation-dependent destabilization of PER2 protein; SIK3 knockdown increases PER2 protein levels while SIK3 overexpression decreases them; Sik3-deficient mice show elevated PER2 in fibroblasts and liver and lengthened circadian period.","method":"Sik3 knockout and knockdown in cells, western blot for PER2 protein levels, bioluminescence rhythm recording, liver fractionation","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO in vivo plus cell-based gain/loss-of-function; single lab","pmids":["29227248"],"is_preprint":false},{"year":2016,"finding":"SIRT1 and PER2 form a reciprocal negative regulation loop: SIRT1 deficiency leads to enhanced H4K16 acetylation at the Per2 promoter causing Per2 overexpression; in turn, PER2 suppresses Sirt1 transcription by binding to the Sirt1 promoter at the Clock/Bmal1 site.","method":"Sirt1-deficient mouse model, ChIP assay for H4K16 acetylation at Per2 promoter, chromatin binding of PER2 at Sirt1 promoter, human hepatocyte validation","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP in vivo plus functional reciprocal regulation; replicated in human cells","pmids":["27346580"],"is_preprint":false},{"year":2019,"finding":"SIRT6 interacts with and deacetylates PER2, preventing its proteasomal degradation; loss of Sirt6 disrupts circadian phase.","method":"Co-immunoprecipitation, deacetylation assay, Sirt6-knockout cells, circadian phase analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus enzymatic deacetylation assay; single lab","pmids":["30782483"],"is_preprint":false},{"year":2015,"finding":"Clock-Bmal1 recruits the Ddb1-Cullin-4 ubiquitin ligase to Per1 and Per2 gene loci; rhythmic H2B monoubiquitination at Per genes depends on Bmal1, Ddb1, and Cullin-4a; this chromatin mark facilitates subsequent recruitment of the Per repressor complex to Clock-Bmal1 on DNA.","method":"ChIP for H2B monoubiquitination, depletion of Ddb1-Cullin-4a, circadian reporter assay, Co-IP of Per complex with Clock-Bmal1","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple chromatin methods, functional depletion, mechanistic demonstration of licensing step","pmids":["26323038"],"is_preprint":false},{"year":2021,"finding":"PER2 acts as a co-factor of CREB to facilitate assembly of the CREB/CRTC1/CBP transactivation complex on the CRE element of the Per1 gene regulatory region in response to light or forskolin; absence of PER2 abolishes CBP-CREB interaction, reduces histone H3 acetylation at the Per1 gene, and decreases RNA Pol II recruitment.","method":"In vitro and in vivo CREB/CRTC1/CBP interaction assays, ChIP for H3 acetylation and RNA Pol II, Per2-/- mouse light-stimulation experiments","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — multiple co-IP and ChIP experiments plus in vivo validation; single lab","pmids":["34741086"],"is_preprint":false},{"year":2010,"finding":"The PAS-B domain of mouse PER2 binds Fe(III) heme with 1:1 stoichiometry using His454 as an axial ligand; heme binding is pH-sensitive and shows faster dissociation kinetics than myoglobin, distinct from the PAS-A domain properties.","method":"Spectroscopic characterization (UV-Vis, CD), diethylpyrocarbonate treatment, H454A point mutant, heme dissociation kinetics","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro biochemical characterization with mutagenesis; single lab","pmids":["20887817"],"is_preprint":false},{"year":2004,"finding":"Per2(Brdm1) mutant mice (with PAS domain deletion) show reduced expression of glutamate transporter Eaat1 in astrocytes, leading to decreased glutamate uptake, elevated extracellular glutamate, and increased alcohol consumption; acamprosate normalizes glutamate levels and alcohol intake in these mice.","method":"Per2 mutant mouse analysis, glutamate transporter expression and glutamate uptake assays, acamprosate pharmacological rescue, alcohol consumption measurement","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic mouse model with biochemical mechanism (transporter expression, glutamate levels) and pharmacological rescue; highly cited foundational paper","pmids":["15608650"],"is_preprint":false},{"year":2007,"finding":"PER2 physically interacts with ERα (estrogen receptor-alpha); PER2 binding enhances ERα degradation, while Per2 suppression stabilizes ERα; PER2 overexpression in breast cancer cells causes growth inhibition, loss of clonogenic ability, and apoptosis; Per2 itself is estrogen-inducible suggesting a feedback loop.","method":"Co-immunoprecipitation, Per2 overexpression/knockdown, ERα stability (cycloheximide chase), colony formation and apoptosis assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP plus functional cell biology; single lab","pmids":["17599055"],"is_preprint":false},{"year":2014,"finding":"KSRP promotes decay of Per2 mRNA through direct RNA-protein interaction with the AU-rich element in the Per2 3' UTR; KSRP ablation increases Per2 expression and delays circadian phase of clock genes in liver, leading to reduced lipogenic gene expression.","method":"RNA-protein interaction assay, heterologous mRNA reporter with Per2 3' UTR, Ksrp-/- mice, primary hepatocyte culture, qRT-PCR","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 — direct RNA-protein interaction demonstrated plus in vivo genetic validation","pmids":["25514904"],"is_preprint":false},{"year":2023,"finding":"PER2 binds to HSP90 through its PAS1 domain, reducing the interaction of HSP90 with IKKα/β; this promotes IKKα/β ubiquitination and inhibits IKK/NF-κB pathway activity, thereby suppressing PD-L1 expression in oral squamous cell carcinoma.","method":"Co-immunoprecipitation, GST pull-down, CHX chase assay, PAS1 domain deletion mutant, IKK ubiquitination assay, in vivo xenograft model","journal":"Journal for immunotherapy of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — GST pull-down plus co-IP with domain mapping and functional in vivo validation; single lab","pmids":["37914384"],"is_preprint":false},{"year":2021,"finding":"Per1 and Per2 are required for activation of Igf2 (an autocrine promoter of myoblast differentiation); Per1/Per2 depletion suppresses RNA Pol II recruitment, reduces dynamic histone modifications at the Igf2 promoter and enhancer, and disrupts promoter-enhancer interaction, thereby impairing myoblast differentiation and muscle regeneration.","method":"Per1/Per2 siRNA depletion in myoblasts, ChIP for histone modifications and RNA Pol II, chromatin conformation capture, in vivo muscle regeneration after cardiotoxin injury","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP, chromatin conformation, and in vivo regeneration with multiple orthogonal methods","pmids":["34009269"],"is_preprint":false},{"year":2013,"finding":"TNF-α inhibits Per2 transcription in rheumatoid synovial cells through D-box binding proteins DBP, HLF, TEF (activators) and E4BP4 (repressor); mutation of D-box 1 and D-box 2 motifs in the Per2 promoter abolished TNF-α-mediated transcriptional inhibition.","method":"Site-directed mutagenesis of Per2 promoter D-box motifs, luciferase reporter assay, qRT-PCR in primary synovial cells","journal":"Scandinavian journal of rheumatology","confidence":"Medium","confidence_rationale":"Tier 2 — promoter mutagenesis plus reporter assay in primary human cells; single lab","pmids":["23496259"],"is_preprint":false},{"year":2023,"finding":"A minimal upstream open reading frame (uORF) in the 5' UTR of Per2 mediates temperature-dependent translational upregulation of PER2 protein without affecting Per2 transcription; PI3K lies upstream of this uORF-mediated translation; genetic ablation of the Per2 uORF impairs entrainment of cells to physiological body temperature cycles and delays wound healing in vivo.","method":"Genetic uORF ablation (knock-in mice), ribosome profiling, PI3K inhibition, cell entrainment to temperature cycles, wound healing assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo knock-in plus ribosome profiling and functional rescue; multiple orthogonal methods","pmids":["36882059"],"is_preprint":false},{"year":2013,"finding":"Egr1 binds directly to two Egr1-binding sites (EBS) in the Per2 promoter (positions -180 to -100) and mediates lithium-induced Per2 transcription; lithium activates the ERK1/2/Elk1 pathway to induce Egr1, which then drives Per2 expression; Egr1-/- mice show attenuated Per2 induction by lithium in frontal cortex.","method":"Serial promoter deletion reporter assays, EBS point mutation, EMSA, ChIP, Egr1 siRNA and Egr1-/- mouse","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1-2 — EMSA + ChIP + promoter mutagenesis + in vivo validation in Egr1-/- mouse","pmids":["23816566"],"is_preprint":false},{"year":2014,"finding":"Sevoflurane anesthesia reduces CLOCK binding to the E'-box in the Per2 promoter and decreases histone H4 acetylation at the proximal Per2 promoter region, suppressing Per2 expression in the SCN; this occurs independently of NAD+ levels in the SCN.","method":"ChIP with anti-acetylated histone H4 and anti-CLOCK antibodies, LC-MS for SCN NAD+ levels, in vitro SCN explant culture with Per2-dLuc reporter","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-based mechanism in vivo and in vitro SCN explant; single lab","pmids":["24498074"],"is_preprint":false},{"year":2012,"finding":"PER2 regulates AKT activity; cells with downregulated PER2 show prolonged high-level AKT T308 phosphorylation after growth factor stimulation or DNA damage; PER2 knockdown also delays DNA damage-induced Chk2 activation and overrides DNA damage-induced apoptosis and cell cycle arrest.","method":"PER2 siRNA knockdown, western blot for p-AKT T308 and p-Chk2, DNA damage assays, apoptosis and cell cycle analysis","journal":"Biochemistry and cell biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — siRNA loss-of-function with multiple signaling readouts; single lab","pmids":["22905719"],"is_preprint":false},{"year":2010,"finding":"Per2 deficiency enhances Ucp2 gene expression in the liver; absence of Per2 causes elevated Clock expression which drives Ucp2 upregulation via a Clock-controlled PPARα signal transduction pathway, leading to decreased intracellular ATP and increased susceptibility to CCl4-induced hepatotoxicity.","method":"Per2-null mice, qRT-PCR and protein analysis of Ucp2/Clock/PPARα, ATP measurement, histological analysis of liver injury","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2-3 — in vivo genetic model with pathway dissection; single lab","pmids":["19056852"],"is_preprint":false},{"year":2019,"finding":"PER2 periodically suppresses PCNA transcription by displacing the CLOCK-BMAL1 heterodimer from the PCNA promoter in a CRY1/2-dependent manner, thereby impeding oxaliplatin-induced DNA adduct repair in oral squamous cell carcinoma cells.","method":"Chromatin immunoprecipitation (pulldown) of CLOCK-BMAL1 from PCNA promoter, PER2 overexpression/knockdown, CRY1/2-dependent co-expression experiments, DNA adduct repair assays","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP-based promoter occupancy assay plus functional DNA repair readout; single lab","pmids":["31728273"],"is_preprint":false},{"year":2021,"finding":"PER2-mediated ameloblast differentiation operates through the PPARγ/AKT1/β-catenin signaling axis; Per2 knockdown decreases PPARγ expression and AKT1 phosphorylation and alters β-catenin localization; overexpression of PPARγ partially rescues Per2 knockdown phenotypes.","method":"Per2 knockdown by RNAi in ameloblast-lineage cells (ALC), overexpression of PPARγ as rescue, western blot for pathway components, in vivo circadian disruption mouse model with PPARγ agonist rescue","journal":"International journal of oral science","confidence":"Medium","confidence_rationale":"Tier 2-3 — RNAi KD with pathway rescue in vitro and in vivo; single lab","pmids":["34011974"],"is_preprint":false},{"year":2010,"finding":"Endogenous dopamine regulates the daily rhythm of PER2 expression in the dorsal striatum through daily activation of D2 (but not D1) dopamine receptors; depletion of striatal dopamine (6-OHDA or α-methyl-para-tyrosine) or D2 receptor blockade blunts the PER2 rhythm; timed D2 receptor activation restores and entrains PER2 rhythm in dopamine-depleted striatum.","method":"6-OHDA and AMPT dopamine depletion, receptor-specific pharmacology (raclopride D2 blockade, D1/D2 agonists), immunohistochemistry for PER2 in rat brain regions","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection with multiple receptor-specific interventions and timed rescue; single lab","pmids":["20962226"],"is_preprint":false},{"year":2008,"finding":"Estrogen directly affects the circadian clock in the uterus: 17β-estradiol (E2) applied to explanted uterus cultures shortens the period of PER2::LUC expression; this effect is attenuated by raloxifene (estrogen receptor antagonist), indicating estrogen acts via estrogen receptors to modulate PER2 rhythms in the uterus but not the SCN.","method":"PER2::LUC tissue explant culture from ovariectomized knockin mice, estrogen/raloxifene treatment, bioluminescence recording","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — direct tissue explant experiment with pharmacological receptor dissection; single lab","pmids":["18728223"],"is_preprint":false},{"year":2006,"finding":"Per2 mutant mice lack food-anticipatory activity under restricted feeding conditions, while Per1 mutants and wild-type mice show normal food anticipation; peripheral phase shifts of clock-gene expression in response to timed food restriction are comparable across all genotypes, placing PER2 specifically in a central food-entrainable oscillator pathway but not peripheral feeding synchronization.","method":"Per2 and Per1 mutant mouse behavioral analysis (rest-activity, body temperature rhythms), clock-gene expression in SCN and peripheral tissues under restricted feeding","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in mouse model with specific behavioral and molecular readouts; independently consistent across multiple organs","pmids":["17055980"],"is_preprint":false},{"year":2017,"finding":"Per2 mutation in mice (PAS domain deletion) is associated with increased cyclooxygenase-1 (but not COX-2) protein levels in aorta, decreased NO production, and altered prostaglandin production, leading to impaired endothelium-dependent relaxation; endothelial dysfunction is not associated with hypertension or dyslipidemia.","method":"Organ chamber studies with aortic rings, Western blot for COX-1/COX-2/eNOS, pharmacological dissection with indomethacin, Per2 mutant mouse model","journal":"Circulation","confidence":"Medium","confidence_rationale":"Tier 2-3 — genetic mouse model with ex vivo vascular function assays and protein expression analysis; single lab","pmids":["17404161"],"is_preprint":false},{"year":2015,"finding":"Per2 mutation in MEFs increases resistance to ROS-induced cytotoxicity; this is paralleled by altered Bcl-2 expression; elevated survival and altered NADH/NAD+ ratio in mutant cells is reversed by reintroduction of wild-type Per2; clock-synchronized cells display time-dependent sensitivity to paraquat.","method":"Per2 mutant MEFs, ROS (paraquat) treatment, cell viability assay, Bcl-2 expression, NADH/NAD+ measurement, wild-type Per2 rescue","journal":"Frontiers in neurology","confidence":"Medium","confidence_rationale":"Tier 2-3 — genetic loss-of-function with rescue experiment; multiple biochemical readouts; single lab","pmids":["25628599"],"is_preprint":false},{"year":2023,"finding":"PER2 enhances HIF-1α transcriptional activity to induce cell cycle genes Ccnb2, Cdc20, and Espl1 in pituitary cells; PER2 upregulation in jet-lagged mice accelerates pituitary adenoma growth, while Per2 loss protects against estrogen-induced pituitary adenoma; SR8278 (which decreases PER2 expression) has anti-tumor effects.","method":"RNA-seq, in vivo jet-lag and estrogen-induced pituitary adenoma models, PER2 overexpression/KO, HIF-1α ChIP, luciferase reporter for HIF-1α target genes","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic model plus mechanistic ChIP; multiple orthogonal approaches; single lab","pmids":["37215573"],"is_preprint":false}],"current_model":"PER2 is a core negative-limb component of the mammalian circadian transcription-translation feedback loop that physically interacts with BMAL1, CLOCK, and CRY proteins to repress CLOCK-BMAL1-driven transcription; its abundance is primarily controlled by a CK1δ/ε-driven multisite phosphoswitch in which priming phosphorylation stabilizes PER2 (extending period) while phosphorylation at the Ser478 phosphodegron recruits β-TrCP E3 ubiquitin ligase for proteasomal degradation, a process counteracted by PP1-mediated dephosphorylation and modulated by SIRT1/SIRT6-mediated deacetylation; nuclear entry of PER2 requires CRY proteins and is facilitated by PML, while a 5' uORF enables temperature-dependent translational upregulation; beyond timekeeping, PER2 functions as a transcriptional co-factor (with CREB/CRTC1/CBP on the Per1 CRE, and with HIF-1α at hypoxia-response elements), regulates glutamatergic, dopaminergic, and estrogen receptor signaling, suppresses IKK/NF-κB and AKT pathways, and controls fatty acid metabolism, thereby linking the circadian clock to cancer suppression, metabolic regulation, and cardiovascular function."},"narrative":{"teleology":[{"year":2002,"claim":"Establishing PER2 as part of an interlocked feedback loop — not merely a repressor — resolved how Bmal1 transcription is sustained, showing PER2 positively drives Bmal1 expression while CLOCK–BMAL1 represses it.","evidence":"Promoter-reporter luciferase assays measuring Bmal1 transcription in the presence of PER2, CRY1, and CRY2","pmids":["11798163"],"confidence":"Medium","gaps":["Mechanism by which PER2 activates Bmal1 transcription (direct DNA binding vs. cofactor role) was not resolved","In vivo validation not provided"]},{"year":2004,"claim":"Demonstrating that Per2 mutation reduces astrocytic glutamate transporter Eaat1 expression and increases alcohol intake established PER2 as a regulator of glutamatergic signaling and addiction-relevant behavior.","evidence":"Per2(Brdm1) mutant mice with glutamate uptake assays and pharmacological rescue by acamprosate","pmids":["15608650"],"confidence":"High","gaps":["Whether PER2 directly regulates Eaat1 transcription or acts indirectly was not determined","Mechanism linking PAS domain deletion to transporter downregulation unknown"]},{"year":2005,"claim":"Identifying the CKIε→β-TrCP→proteasome degradation axis for PER2 defined the primary mechanism controlling PER2 protein clearance and linked kinase activity to circadian period length.","evidence":"Dominant-negative β-TrCP, CKIε inhibition, proteasome inhibitors, and period measurement in Rat-1 cells","pmids":["15767683"],"confidence":"High","gaps":["Specific phosphodegron residue not yet mapped","Relative contributions of CKIε vs. CKIδ to PER2 degradation in vivo unresolved"]},{"year":2006,"claim":"Showing that PP1 dephosphorylates CKI-phosphorylated PER2 to stabilize it established a kinase–phosphatase balance as the tuning mechanism for PER2 half-life and, by extension, circadian period.","evidence":"Co-IP of PER2 with PP1c in HEK-293 cells, mouse liver and brain; dominant-negative PP1c and inhibitor treatment accelerated PER2 degradation","pmids":["16813562"],"confidence":"High","gaps":["Which PP1 regulatory subunit targets PP1 to PER2 was not identified","Whether PP1 acts on the stabilizing or degron phosphosites was unknown"]},{"year":2006,"claim":"Per2 mutant mice specifically lacking food-anticipatory activity revealed PER2 as an essential component of a food-entrainable oscillator distinct from the SCN master clock.","evidence":"Behavioral and molecular analysis of Per2 vs. Per1 mutant mice under restricted feeding","pmids":["17055980"],"confidence":"High","gaps":["Anatomical locus of the food-entrainable oscillator not identified","Molecular mechanism by which PER2 contributes to food anticipation unclear"]},{"year":2007,"claim":"The FASPS S662G mutation in PER2 established the phosphoswitch model: CKIδ-mediated phosphorylation at S662 stabilizes PER2, and loss of this phosphorylation shortens period and causes familial advanced sleep phase syndrome in humans.","evidence":"Transgenic mice carrying human PER2 S662G, in vitro CKI phosphorylation, CKIδ dosage manipulation","pmids":["17218255"],"confidence":"High","gaps":["How S662 phosphorylation mechanistically opposes degron-directed phosphorylation was not resolved","Structural basis of the phosphoswitch unknown"]},{"year":2007,"claim":"PER2 interaction with ERα and promotion of its degradation linked the circadian clock to estrogen signaling and breast cancer cell growth control.","evidence":"Co-IP of PER2–ERα, cycloheximide chase showing enhanced ERα degradation upon PER2 overexpression, growth inhibition and apoptosis in breast cancer cells","pmids":["17599055"],"confidence":"Medium","gaps":["Whether PER2 recruits a specific E3 ligase to ERα was not determined","Single lab; not independently confirmed"]},{"year":2008,"claim":"Mapping PER2 physical interactions with BMAL1 and CLOCK via distinct domains (separate from CRY interaction domains) defined the architecture of the repressive complex on E-box elements.","evidence":"Mammalian two-hybrid and co-immunoprecipitation in HEK-293 cells","pmids":["18430226"],"confidence":"Medium","gaps":["Stoichiometry and dynamics of the repressive complex in living cells unresolved","Single interaction methodology per pair"]},{"year":2010,"claim":"Demonstrating that PER2's PAS-B domain binds Fe(III) heme with 1:1 stoichiometry raised the possibility that PER2 senses metabolic/redox state, though functional consequences remained undefined.","evidence":"UV-Vis/CD spectroscopy, H454A mutagenesis, heme dissociation kinetics","pmids":["20887817"],"confidence":"Medium","gaps":["Physiological role of heme binding in circadian regulation not established","In vivo relevance not tested"]},{"year":2012,"claim":"PML was identified as a nuclear import facilitator for PER2, linking PML body dynamics and SIRT1-mediated deacetylation of PML to circadian clock function in SCN neurons.","evidence":"Co-IP of PER2–PML, immunofluorescence in SCN, Pml−/− mice showing cytoplasmic PER2 redistribution, SIRT1 deacetylation of PML-K487","pmids":["22274616"],"confidence":"High","gaps":["Whether PML acts as a direct nuclear import chaperone or indirectly through PML bodies was not distinguished","Relative contribution of PML vs. CRY-dependent import not quantified"]},{"year":2015,"claim":"Discovery that CLOCK–BMAL1 recruits the DDB1–CUL4 ubiquitin ligase to Per loci for rhythmic H2B monoubiquitination established a chromatin licensing step required for PER2 repressor complex recruitment to its own promoter.","evidence":"ChIP for H2Bub at Per genes, DDB1-CUL4a depletion, circadian reporter assays","pmids":["26323038"],"confidence":"High","gaps":["Whether H2Bub is specifically required for PER2 or for the entire PER–CRY complex was not separated","Mechanism linking monoubiquitination to repressor docking not defined"]},{"year":2018,"claim":"Unified phosphoswitch model: CK1δ/ε serves as both priming kinase and downstream kinase on PER2, with CK1 splice variants and C-terminal tail modulating period sensitivity — resolving the paradox of how a single kinase family produces both stabilizing and destabilizing phosphorylation.","evidence":"Biochemical reconstitution of PER2 priming phosphorylation, mathematical modeling, CK1 splice-variant comparison","pmids":["29784789"],"confidence":"High","gaps":["Full phosphosite map of endogenous PER2 in vivo not available","Role of other kinases (e.g., SIK3) in the phosphoswitch hierarchy unclear"]},{"year":2020,"claim":"The PER2-S478A knock-in mouse definitively identified S478 as the β-TrCP phosphodegron site in vivo, showing that blocking this single phosphorylation lengthens period, accumulates PER2 in both compartments, and disrupts temperature compensation.","evidence":"Knock-in mouse behavioral and molecular analysis, PER2::LUC fibroblast bioluminescence","pmids":["32354999"],"confidence":"High","gaps":["Whether S478 phosphorylation is the sole degradation trigger or acts in concert with other degron sites","Structural basis of β-TrCP recognition of phospho-S478 peptide not determined"]},{"year":2020,"claim":"An anion binding site in CK1 controls activation loop conformation and determines which PER2 phosphosites (stabilizing vs. destabilizing) are preferentially targeted, providing a structural explanation for period-altering CK1 mutations across species.","evidence":"CK1 anion-binding-site mutagenesis, PER2 phosphorylation/stability measurements, cross-species comparison","pmids":["32043967"],"confidence":"High","gaps":["Whether intracellular anion concentrations physiologically modulate this switch is unknown","No full crystal structure of CK1 bound to PER2 peptide"]},{"year":2021,"claim":"PER2 was shown to function as a transcriptional co-activator at the Per1 CRE by assembling the CREB/CRTC1/CBP complex, establishing that PER2 has a direct positive transcriptional role beyond its canonical repressor function.","evidence":"In vitro/in vivo CREB–CRTC1–CBP interaction assays, ChIP for H3 acetylation and RNA Pol II at Per1, light-stimulation in Per2−/− mice","pmids":["34741086"],"confidence":"Medium","gaps":["Whether PER2 directly contacts CRE DNA or acts solely as a scaffold was not determined","Generalizability of co-activator role beyond Per1 not tested"]},{"year":2022,"claim":"CRY proteins were established as essential gatekeepers for PER2 nuclear entry in SCN neurons, with the CRY1 C-terminal tail required for relocalization — clarifying why CRY loss abolishes circadian rhythms even when PER2 is present.","evidence":"Confocal imaging and FRAP of PER2::Venus in Cry-null SCN, viral CRY1/CRY2 rescue, CRY1 tail deletion","pmids":["35046033"],"confidence":"High","gaps":["Whether CRY masks a PER2 nuclear export signal or actively drives import is unknown","Relative contributions of CRY1 vs. CRY2 to PER2 import quantitatively unresolved"]},{"year":2023,"claim":"A 5′ uORF in Per2 mRNA was identified as a temperature-sensing translational switch controlled by PI3K, providing a mechanism for peripheral temperature entrainment independent of transcriptional regulation.","evidence":"uORF knock-in ablation mice, ribosome profiling, PI3K inhibition, temperature-cycle entrainment assays, wound-healing assay","pmids":["36882059"],"confidence":"High","gaps":["Identity of the PI3K-regulated factor that modulates uORF bypass unknown","Whether this mechanism operates in SCN neurons not tested"]},{"year":2023,"claim":"PER2 was shown to suppress IKK/NF-κB signaling by competitively binding HSP90 through its PAS1 domain, promoting IKKα/β ubiquitination and reducing PD-L1 expression — extending PER2's tumor-suppressive functions to immune evasion.","evidence":"GST pull-down, co-IP, PAS1 deletion mutant, IKK ubiquitination assay, xenograft model in oral squamous cell carcinoma","pmids":["37914384"],"confidence":"Medium","gaps":["Whether PER2–HSP90 interaction is circadian-gated not tested","Single cancer type; generalizability to other tissues unknown"]},{"year":null,"claim":"Key open questions include: the full structural basis of the CK1–PER2 phosphoswitch complex, how PER2 coordinates its dual repressor and co-activator transcriptional roles genome-wide, the identity of the food-entrainable oscillator circuit in which PER2 is essential, and whether heme binding to the PAS-B domain has a physiological signaling role.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of full-length PER2 in complex with CK1 or CRY","Genome-wide map of PER2 co-activator vs. repressor targets unavailable","Anatomical and molecular identity of PER2-dependent food-entrainable oscillator undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[7,8,16,29]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[19,21,27]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,9,10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,10]}],"pathway":[{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[0,1,4,5,6,7,8]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,15,16,22]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[21,27,30]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,2,3,5]}],"complexes":["PER–CRY repressor complex","CLOCK–BMAL1–PER2 complex"],"partners":["CRY1","CRY2","BMAL1","CLOCK","CSNK1D","CSNK1E","BTRC","PML"],"other_free_text":[]},"mechanistic_narrative":"PER2 is a core component of the mammalian circadian transcription–translation feedback loop that represses CLOCK–BMAL1-driven transcription while simultaneously activating Bmal1 expression, thereby sustaining oscillatory gene expression across tissues. PER2 protein abundance is governed by a CK1δ/ε-dependent phosphoswitch: priming phosphorylation at S662 stabilizes PER2 and lengthens circadian period, whereas phosphorylation at S478 creates a β-TrCP phosphodegron that targets PER2 for ubiquitin–proteasome degradation — a balance modulated by PP1 dephosphorylation, SIRT6-mediated deacetylation, and a 5′ uORF that confers temperature-dependent translational control [PMID:17218255, PMID:32354999, PMID:15767683, PMID:16813562, PMID:30782483, PMID:36882059]. Nuclear entry of PER2 requires CRY proteins and is facilitated by PML, and once nuclear, PER2 acts as a transcriptional co-factor — assembling the CREB/CRTC1/CBP complex at the Per1 CRE, enhancing HIF-1α recruitment to hypoxia-response elements, and displacing CLOCK–BMAL1 from target promoters such as PCNA [PMID:35046033, PMID:22274616, PMID:34741086, PMID:28963769, PMID:31728273]. Beyond timekeeping, PER2 links the clock to metabolism, vascular function, and tumor suppression by regulating glutamate transporter expression, estrogen receptor α stability, IKK/NF-κB signaling via competitive HSP90 binding, and AKT pathway activity [PMID:15608650, PMID:17599055, PMID:37914384, PMID:22905719]."},"prefetch_data":{"uniprot":{"accession":"O15055","full_name":"Period circadian protein homolog 2","aliases":["Circadian clock protein PERIOD 2"],"length_aa":1255,"mass_kda":136.6,"function":"Transcriptional repressor which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndrome and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress BMAL1 transcription, respectively. PER1 and PER2 proteins transport CRY1 and CRY2 into the nucleus with appropriate circadian timing, but also contribute directly to repression of clock-controlled target genes through interaction with several classes of RNA-binding proteins, helicases and others transcriptional repressors. PER appears to regulate circadian control of transcription by at least three different modes. First, interacts directly with the CLOCK-BMAL1 at the tail end of the nascent transcript peak to recruit complexes containing the SIN3-HDAC that remodel chromatin to repress transcription. Second, brings H3K9 methyltransferases such as SUV39H1 and SUV39H2 to the E-box elements of the circadian target genes, like PER2 itself or PER1. The recruitment of each repressive modifier to the DNA seems to be very precisely temporally orchestrated by the large PER complex, the deacetylases acting before than the methyltransferases. Additionally, large PER complexes are also recruited to the target genes 3' termination site through interactions with RNA-binding proteins and helicases that may play a role in transcription termination to regulate transcription independently of CLOCK-BMAL1 interactions. Recruitment of large PER complexes to the elongating polymerase at PER and CRY termination sites inhibited SETX action, impeding RNA polymerase II release and thereby repressing transcriptional reinitiation. May propagate clock information to metabolic pathways via the interaction with nuclear receptors. Coactivator of PPARA and corepressor of NR1D1, binds rhythmically at the promoter of nuclear receptors target genes like BMAL1 or G6PC1. Directly and specifically represses PPARG proadipogenic activity by blocking PPARG recruitment to target promoters and thereby inhibiting transcriptional activation. Required for fatty acid and lipid metabolism, is involved as well in the regulation of circulating insulin levels. Plays an important role in the maintenance of cardiovascular functions through the regulation of NO and vasodilatatory prostaglandins production in aortas. Controls circadian glutamate uptake in synaptic vesicles through the regulation of VGLUT1 expression. May also be involved in the regulation of inflammatory processes. Represses the CLOCK-BMAL1 induced transcription of BHLHE40/DEC1 and ATF4. Negatively regulates the formation of the TIMELESS-CRY1 complex by competing with TIMELESS for binding to CRY1","subcellular_location":"Nucleus, nucleolus","url":"https://www.uniprot.org/uniprotkb/O15055/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PER2","classification":"Not Classified","n_dependent_lines":24,"n_total_lines":1208,"dependency_fraction":0.019867549668874173},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PER2","total_profiled":1310},"omim":[{"mim_id":"619771","title":"VRK SERINE/THREONINE KINASE 3; VRK3","url":"https://www.omim.org/entry/619771"},{"mim_id":"616882","title":"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3","url":"https://www.omim.org/entry/616882"},{"mim_id":"614776","title":"SIK FAMILY KINASE 3; SIK3","url":"https://www.omim.org/entry/614776"},{"mim_id":"614517","title":"BRAIN AND MUSCLE ARNT-LIKE PROTEIN 2; BMAL2","url":"https://www.omim.org/entry/614517"},{"mim_id":"610016","title":"MICRO RNA 132; MIR132","url":"https://www.omim.org/entry/610016"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PER2"},"hgnc":{"alias_symbol":["KIAA0347"],"prev_symbol":[]},"alphafold":{"accession":"O15055","domains":[{"cath_id":"3.30.450.20","chopping":"149-155_170-317","consensus_level":"medium","plddt":81.071,"start":149,"end":317},{"cath_id":"3.30.450.20","chopping":"319-449_457-473","consensus_level":"medium","plddt":91.527,"start":319,"end":473}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O15055","model_url":"https://alphafold.ebi.ac.uk/files/AF-O15055-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O15055-F1-predicted_aligned_error_v6.png","plddt_mean":52.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PER2","jax_strain_url":"https://www.jax.org/strain/search?query=PER2"},"sequence":{"accession":"O15055","fasta_url":"https://rest.uniprot.org/uniprotkb/O15055.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O15055/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O15055"}},"corpus_meta":[{"pmid":"15608650","id":"PMC_15608650","title":"The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption.","date":"2004","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15608650","citation_count":462,"is_preprint":false},{"pmid":"15767683","id":"PMC_15767683","title":"Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15767683","citation_count":403,"is_preprint":false},{"pmid":"17218255","id":"PMC_17218255","title":"Modeling of a human circadian mutation yields insights into clock regulation by PER2.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17218255","citation_count":316,"is_preprint":false},{"pmid":"15790588","id":"PMC_15790588","title":"Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.","date":"2005","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/15790588","citation_count":311,"is_preprint":false},{"pmid":"17404161","id":"PMC_17404161","title":"Mutation of the circadian clock gene Per2 alters vascular endothelial function.","date":"2007","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/17404161","citation_count":190,"is_preprint":false},{"pmid":"20962226","id":"PMC_20962226","title":"Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20962226","citation_count":190,"is_preprint":false},{"pmid":"17055980","id":"PMC_17055980","title":"Lack of food anticipation in Per2 mutant mice.","date":"2006","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/17055980","citation_count":171,"is_preprint":false},{"pmid":"17599055","id":"PMC_17599055","title":"The clock gene Per2 links the circadian system to the estrogen receptor.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17599055","citation_count":164,"is_preprint":false},{"pmid":"11982626","id":"PMC_11982626","title":"Gradients in the circadian expression of Per1 and Per2 genes in the rat suprachiasmatic nucleus.","date":"2002","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11982626","citation_count":127,"is_preprint":false},{"pmid":"15985538","id":"PMC_15985538","title":"Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15985538","citation_count":127,"is_preprint":false},{"pmid":"29784789","id":"PMC_29784789","title":"CK1δ/ε protein kinase primes the PER2 circadian phosphoswitch.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29784789","citation_count":122,"is_preprint":false},{"pmid":"18517031","id":"PMC_18517031","title":"Inter-individual differences in habitual sleep timing and entrained phase of endogenous circadian rhythms of BMAL1, PER2 and PER3 mRNA in human leukocytes.","date":"2008","source":"Sleep","url":"https://pubmed.ncbi.nlm.nih.gov/18517031","citation_count":119,"is_preprint":false},{"pmid":"11798163","id":"PMC_11798163","title":"Interactivating feedback loops within the mammalian clock: BMAL1 is negatively autoregulated and upregulated by CRY1, CRY2, and PER2.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11798163","citation_count":117,"is_preprint":false},{"pmid":"18430226","id":"PMC_18430226","title":"Interaction of circadian clock proteins PER2 and CRY with BMAL1 and CLOCK.","date":"2008","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18430226","citation_count":115,"is_preprint":false},{"pmid":"18728223","id":"PMC_18728223","title":"Estrogen directly modulates circadian rhythms of PER2 expression in the uterus.","date":"2008","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18728223","citation_count":110,"is_preprint":false},{"pmid":"16519674","id":"PMC_16519674","title":"Evening exposure to blue light stimulates the expression of the clock gene PER2 in humans.","date":"2006","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16519674","citation_count":101,"is_preprint":false},{"pmid":"27346580","id":"PMC_27346580","title":"Negative reciprocal regulation between Sirt1 and Per2 modulates the circadian clock and aging.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27346580","citation_count":77,"is_preprint":false},{"pmid":"22479387","id":"PMC_22479387","title":"Persistent cell-autonomous circadian oscillations in fibroblasts revealed by six-week single-cell imaging of PER2::LUC bioluminescence.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22479387","citation_count":72,"is_preprint":false},{"pmid":"20481271","id":"PMC_20481271","title":"Deregulated expression of the Per1 and Per2 in human gliomas.","date":"2010","source":"The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","url":"https://pubmed.ncbi.nlm.nih.gov/20481271","citation_count":67,"is_preprint":false},{"pmid":"20053965","id":"PMC_20053965","title":"Role of mutation of the circadian clock gene Per2 in cardiovascular circadian rhythms.","date":"2010","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20053965","citation_count":67,"is_preprint":false},{"pmid":"28963769","id":"PMC_28963769","title":"A circadian clock gene, PER2, activates HIF-1 as an effector molecule for recruitment of HIF-1α to promoter regions of its downstream genes.","date":"2017","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/28963769","citation_count":66,"is_preprint":false},{"pmid":"16554373","id":"PMC_16554373","title":"The expression of the clock protein PER2 in the limbic forebrain is modulated by the estrous cycle.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16554373","citation_count":65,"is_preprint":false},{"pmid":"18782782","id":"PMC_18782782","title":"The role of {beta}-TrCP1 and {beta}-TrCP2 in circadian rhythm generation by mediating degradation of clock protein PER2.","date":"2008","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18782782","citation_count":65,"is_preprint":false},{"pmid":"16813562","id":"PMC_16813562","title":"Protein phosphatase 1 regulates the stability of the circadian protein PER2.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16813562","citation_count":64,"is_preprint":false},{"pmid":"23977055","id":"PMC_23977055","title":"Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23977055","citation_count":64,"is_preprint":false},{"pmid":"20187847","id":"PMC_20187847","title":"The clock gene PER2 and sleep problems: association with alcohol consumption among Swedish adolescents.","date":"2010","source":"Upsala journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20187847","citation_count":62,"is_preprint":false},{"pmid":"25628599","id":"PMC_25628599","title":"The Mammalian circadian clock gene per2 modulates cell death in response to oxidative stress.","date":"2015","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25628599","citation_count":61,"is_preprint":false},{"pmid":"18419266","id":"PMC_18419266","title":"The multiple facets of Per2.","date":"2007","source":"Cold Spring Harbor symposia on quantitative biology","url":"https://pubmed.ncbi.nlm.nih.gov/18419266","citation_count":60,"is_preprint":false},{"pmid":"23193187","id":"PMC_23193187","title":"Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow.","date":"2012","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/23193187","citation_count":58,"is_preprint":false},{"pmid":"23608482","id":"PMC_23608482","title":"The circadian Per1 and Per2 genes influence alcohol intake, reinforcement, and blood alcohol levels.","date":"2013","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/23608482","citation_count":57,"is_preprint":false},{"pmid":"32354999","id":"PMC_32354999","title":"Mutation of a PER2 phosphodegron perturbs the circadian phosphoswitch.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32354999","citation_count":56,"is_preprint":false},{"pmid":"32043967","id":"PMC_32043967","title":"Casein kinase 1 dynamics underlie substrate selectivity and the PER2 circadian phosphoswitch.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32043967","citation_count":56,"is_preprint":false},{"pmid":"27494874","id":"PMC_27494874","title":"Clock gene Per2 as a controller of liver carcinogenesis.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27494874","citation_count":54,"is_preprint":false},{"pmid":"23496259","id":"PMC_23496259","title":"TNF-α modulates expression of the circadian clock gene Per2 in rheumatoid synovial cells.","date":"2013","source":"Scandinavian journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/23496259","citation_count":54,"is_preprint":false},{"pmid":"23735497","id":"PMC_23735497","title":"Fibroblast PER2 circadian rhythmicity depends on cell density.","date":"2013","source":"Journal of biological rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/23735497","citation_count":50,"is_preprint":false},{"pmid":"26323038","id":"PMC_26323038","title":"Histone monoubiquitination by Clock-Bmal1 complex marks Per1 and Per2 genes for circadian feedback.","date":"2015","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26323038","citation_count":50,"is_preprint":false},{"pmid":"23159832","id":"PMC_23159832","title":"Influence of aging on Bmal1 and Per2 expression in extra-SCN oscillators in hamster brain.","date":"2012","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/23159832","citation_count":49,"is_preprint":false},{"pmid":"22274616","id":"PMC_22274616","title":"PML regulates PER2 nuclear localization and circadian function.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22274616","citation_count":49,"is_preprint":false},{"pmid":"29223143","id":"PMC_29223143","title":"Neurobiological Functions of the Period Circadian Clock 2 Gene, Per2.","date":"2018","source":"Biomolecules & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/29223143","citation_count":44,"is_preprint":false},{"pmid":"25760074","id":"PMC_25760074","title":"Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25760074","citation_count":43,"is_preprint":false},{"pmid":"32468039","id":"PMC_32468039","title":"PER2 inhibits proliferation and stemness of glioma stem cells via the Wnt/β‑catenin signaling pathway.","date":"2020","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/32468039","citation_count":42,"is_preprint":false},{"pmid":"28448534","id":"PMC_28448534","title":"Intense light-elicited upregulation of miR-21 facilitates glycolysis and cardioprotection through Per2-dependent mechanisms.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28448534","citation_count":42,"is_preprint":false},{"pmid":"19500131","id":"PMC_19500131","title":"Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia.","date":"2009","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/19500131","citation_count":40,"is_preprint":false},{"pmid":"31728273","id":"PMC_31728273","title":"Periodic Oxaliplatin Administration in Synergy with PER2-Mediated PCNA Transcription Repression Promotes Chronochemotherapeutic Efficacy of OSCC.","date":"2019","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/31728273","citation_count":39,"is_preprint":false},{"pmid":"19200536","id":"PMC_19200536","title":"Motivational Modulation of Rhythms of the Expression of the Clock Protein PER2 in the Limbic Forebrain.","date":"2009","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19200536","citation_count":38,"is_preprint":false},{"pmid":"22261359","id":"PMC_22261359","title":"Deletion of clock gene Per2 exacerbates cholestatic liver injury and fibrosis in mice.","date":"2012","source":"Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie","url":"https://pubmed.ncbi.nlm.nih.gov/22261359","citation_count":37,"is_preprint":false},{"pmid":"26207312","id":"PMC_26207312","title":"Melatonin Entrains PER2::LUC Bioluminescence Circadian Rhythm in the Mouse Cornea.","date":"2015","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/26207312","citation_count":35,"is_preprint":false},{"pmid":"16488540","id":"PMC_16488540","title":"Pinealectomy does not affect diurnal PER2 expression in the rat limbic forebrain.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16488540","citation_count":35,"is_preprint":false},{"pmid":"37914384","id":"PMC_37914384","title":"PER2 binding to HSP90 enhances immune response against oral squamous cell carcinoma by inhibiting IKK/NF-κB pathway and PD-L1 expression.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37914384","citation_count":34,"is_preprint":false},{"pmid":"19056852","id":"PMC_19056852","title":"The protective role of Per2 against carbon tetrachloride-induced hepatotoxicity.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19056852","citation_count":33,"is_preprint":false},{"pmid":"34009269","id":"PMC_34009269","title":"Per1/Per2-Igf2 axis-mediated circadian regulation of myogenic differentiation.","date":"2021","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/34009269","citation_count":33,"is_preprint":false},{"pmid":"24498074","id":"PMC_24498074","title":"Epigenetic suppression of mouse Per2 expression in the suprachiasmatic nucleus by the inhalational anesthetic, sevoflurane.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24498074","citation_count":31,"is_preprint":false},{"pmid":"30926824","id":"PMC_30926824","title":"Chronotype Genetic Variant in PER2 is Associated with Intrinsic Circadian Period in Humans.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30926824","citation_count":31,"is_preprint":false},{"pmid":"29227248","id":"PMC_29227248","title":"Salt-inducible kinase 3 regulates the mammalian circadian clock by destabilizing PER2 protein.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29227248","citation_count":30,"is_preprint":false},{"pmid":"31353796","id":"PMC_31353796","title":"Systems approach reveals photosensitivity and PER2 level as determinants of clock-modulator efficacy.","date":"2019","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/31353796","citation_count":30,"is_preprint":false},{"pmid":"18541376","id":"PMC_18541376","title":"Region-specific modulation of PER2 expression in the limbic forebrain and hypothalamus by nighttime restricted feeding in rats.","date":"2008","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/18541376","citation_count":30,"is_preprint":false},{"pmid":"22734566","id":"PMC_22734566","title":"Fibroblast circadian rhythms of PER2 expression depend on membrane potential and intracellular calcium.","date":"2012","source":"Chronobiology international","url":"https://pubmed.ncbi.nlm.nih.gov/22734566","citation_count":30,"is_preprint":false},{"pmid":"21655193","id":"PMC_21655193","title":"A fear-inducing odor alters PER2 and c-Fos expression in brain regions involved in fear memory.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21655193","citation_count":28,"is_preprint":false},{"pmid":"15245489","id":"PMC_15245489","title":"Regulation of photoreceptor Per1 and Per2 by light, dopamine and a circadian clock.","date":"2004","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15245489","citation_count":27,"is_preprint":false},{"pmid":"37215573","id":"PMC_37215573","title":"PER2 integrates circadian disruption and pituitary tumorigenesis.","date":"2023","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/37215573","citation_count":26,"is_preprint":false},{"pmid":"29593513","id":"PMC_29593513","title":"Zebrafish Lacking Circadian Gene per2 Exhibit Visual Function Deficiency.","date":"2018","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29593513","citation_count":26,"is_preprint":false},{"pmid":"30091820","id":"PMC_30091820","title":"The circadian gene, Per2, influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice.","date":"2018","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/30091820","citation_count":26,"is_preprint":false},{"pmid":"28535015","id":"PMC_28535015","title":"The circadian clock gene PER2 plays an important role in tumor suppression through regulating tumor-associated genes in human oral squamous cell carcinoma.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28535015","citation_count":26,"is_preprint":false},{"pmid":"12749028","id":"PMC_12749028","title":"Light exposure during daytime modulates expression of Per1 and Per2 clock genes in the suprachiasmatic nuclei of mice.","date":"2003","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/12749028","citation_count":26,"is_preprint":false},{"pmid":"24133102","id":"PMC_24133102","title":"Organ-specific development characterizes circadian clock gene Per2 expression in rats.","date":"2013","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24133102","citation_count":25,"is_preprint":false},{"pmid":"34112905","id":"PMC_34112905","title":"Deletion of the clock gene Period2 (Per2) in glial cells alters mood-related behavior in mice.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34112905","citation_count":25,"is_preprint":false},{"pmid":"23555676","id":"PMC_23555676","title":"Direct and specific effect of sevoflurane anesthesia on rat Per2 expression in the suprachiasmatic nucleus.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23555676","citation_count":25,"is_preprint":false},{"pmid":"23505514","id":"PMC_23505514","title":"Circadian clock gene Per2 is not necessary for the photoperiodic response in mice.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23505514","citation_count":25,"is_preprint":false},{"pmid":"34741086","id":"PMC_34741086","title":"PER2 mediates CREB-dependent light induction of the clock gene Per1.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34741086","citation_count":24,"is_preprint":false},{"pmid":"36882059","id":"PMC_36882059","title":"Minimal upstream open reading frame of Per2 mediates phase fitness of the circadian clock to day/night physiological body temperature rhythm.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36882059","citation_count":24,"is_preprint":false},{"pmid":"35046033","id":"PMC_35046033","title":"Cryptochrome proteins regulate the circadian intracellular behavior and localization of PER2 in mouse suprachiasmatic nucleus neurons.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35046033","citation_count":24,"is_preprint":false},{"pmid":"23816566","id":"PMC_23816566","title":"Egr1 regulates lithium-induced transcription of the Period 2 (PER2) gene.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23816566","citation_count":24,"is_preprint":false},{"pmid":"34160105","id":"PMC_34160105","title":"Core circadian clock genes Per1 and Per2 regulate the rhythm in photoreceptor outer segment phagocytosis.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/34160105","citation_count":24,"is_preprint":false},{"pmid":"17106427","id":"PMC_17106427","title":"Human clock, PER1 and PER2 polymorphisms: lack of association with cocaine dependence susceptibility and cocaine-induced paranoia.","date":"2006","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17106427","citation_count":24,"is_preprint":false},{"pmid":"27660894","id":"PMC_27660894","title":"Association of CLOCK, ARNTL, PER2, and GNB3 polymorphisms with diurnal preference in a Korean population.","date":"2016","source":"Chronobiology international","url":"https://pubmed.ncbi.nlm.nih.gov/27660894","citation_count":24,"is_preprint":false},{"pmid":"17438050","id":"PMC_17438050","title":"Biochemical characterization of PER-2 and genetic environment of blaPER-2.","date":"2007","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/17438050","citation_count":23,"is_preprint":false},{"pmid":"20887817","id":"PMC_20887817","title":"Heme-binding characteristics of the isolated PAS-B domain of mouse Per2, a transcriptional regulatory factor associated with circadian rhythms.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20887817","citation_count":23,"is_preprint":false},{"pmid":"30782483","id":"PMC_30782483","title":"Sirt6 deacetylase activity regulates circadian rhythms via Per2.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30782483","citation_count":22,"is_preprint":false},{"pmid":"30522007","id":"PMC_30522007","title":"Temporal dynamics of cortisol-associated changes in mRNA expression of glucocorticoid responsive genes FKBP5, GILZ, SDPR, PER1, PER2 and PER3 in healthy humans.","date":"2018","source":"Psychoneuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30522007","citation_count":22,"is_preprint":false},{"pmid":"21624349","id":"PMC_21624349","title":"Light responsiveness of clock genes, Per1 and Per2, in the olfactory bulb of mice.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21624349","citation_count":22,"is_preprint":false},{"pmid":"26152125","id":"PMC_26152125","title":"IA Channels Encoded by Kv1.4 and Kv4.2 Regulate Circadian Period of PER2 Expression in the Suprachiasmatic Nucleus.","date":"2015","source":"Journal of biological rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/26152125","citation_count":21,"is_preprint":false},{"pmid":"30943793","id":"PMC_30943793","title":"Analyses of BMAL1 and PER2 Oscillations in a Model of Breast Cancer Progression Reveal Changes With Malignancy.","date":"2019","source":"Integrative cancer therapies","url":"https://pubmed.ncbi.nlm.nih.gov/30943793","citation_count":21,"is_preprint":false},{"pmid":"30008892","id":"PMC_30008892","title":"Histone deacetylase inhibitors induce the expression of tumor suppressor genes Per1 and Per2 in human gastric cancer cells.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30008892","citation_count":21,"is_preprint":false},{"pmid":"37069338","id":"PMC_37069338","title":"Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c.","date":"2023","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37069338","citation_count":20,"is_preprint":false},{"pmid":"22905719","id":"PMC_22905719","title":"Mammalian PER2 regulates AKT activation and DNA damage response.","date":"2012","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/22905719","citation_count":20,"is_preprint":false},{"pmid":"21186050","id":"PMC_21186050","title":"The clock gene Per2 is required for normal platelet formation and function.","date":"2010","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/21186050","citation_count":20,"is_preprint":false},{"pmid":"29765408","id":"PMC_29765408","title":"The Interaction between Bmal1 and Per2 in Mouse BMSC Osteogenic Differentiation.","date":"2018","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/29765408","citation_count":20,"is_preprint":false},{"pmid":"36285301","id":"PMC_36285301","title":"Attenuation by Time-Restricted Feeding of High-Fat and High-Fructose Diet-Induced NASH in Mice Is Related to Per2 and Ferroptosis.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/36285301","citation_count":20,"is_preprint":false},{"pmid":"26656624","id":"PMC_26656624","title":"Real-Time Recording of Circadian Per1 and Per2 Expression in the Suprachiasmatic Nucleus of Freely Moving Rats.","date":"2015","source":"Journal of biological rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/26656624","citation_count":18,"is_preprint":false},{"pmid":"25514904","id":"PMC_25514904","title":"KSRP is critical in governing hepatic lipid metabolism through controlling Per2 expression.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/25514904","citation_count":18,"is_preprint":false},{"pmid":"35806403","id":"PMC_35806403","title":"Per1/Per2 Disruption Reduces Testosterone Synthesis and Impairs Fertility in Elderly Male Mice.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35806403","citation_count":17,"is_preprint":false},{"pmid":"28213822","id":"PMC_28213822","title":"Effect of lipopolysaccharide on circadian clock genes Per2 and Bmal1 in mouse ovary.","date":"2017","source":"The journal of physiological sciences : JPS","url":"https://pubmed.ncbi.nlm.nih.gov/28213822","citation_count":17,"is_preprint":false},{"pmid":"27740710","id":"PMC_27740710","title":"Differential localization of PER1 and PER2 in the brain master circadian clock.","date":"2016","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27740710","citation_count":16,"is_preprint":false},{"pmid":"25070104","id":"PMC_25070104","title":"Crystal structure of the extended-spectrum β-lactamase PER-2 and insights into the role of specific residues in the interaction with β-lactams and β-lactamase inhibitors.","date":"2014","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/25070104","citation_count":16,"is_preprint":false},{"pmid":"21479457","id":"PMC_21479457","title":"Deregulated expression of the per2 gene in human colorectal carcinoma.","date":"2008","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21479457","citation_count":15,"is_preprint":false},{"pmid":"36284088","id":"PMC_36284088","title":"Loss of thyroid gland circadian PER2 rhythmicity in aged mice and its potential association with thyroid cancer development.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36284088","citation_count":15,"is_preprint":false},{"pmid":"34011974","id":"PMC_34011974","title":"PER2-mediated ameloblast differentiation via PPARγ/AKT1/β-catenin axis.","date":"2021","source":"International journal of oral science","url":"https://pubmed.ncbi.nlm.nih.gov/34011974","citation_count":15,"is_preprint":false},{"pmid":"25313752","id":"PMC_25313752","title":"The analysis of deregulated expression and methylation of the PER2 genes in gliomas.","date":"2014","source":"Journal of cancer research and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25313752","citation_count":14,"is_preprint":false},{"pmid":"34048425","id":"PMC_34048425","title":"Targeted modification of the Per2 clock gene alters circadian function in mPer2luciferase (mPer2Luc) mice.","date":"2021","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/34048425","citation_count":14,"is_preprint":false},{"pmid":"35755440","id":"PMC_35755440","title":"Characterization of Affective Behaviors and Motor Functions in Mice With a Striatal-Specific Deletion of Bmal1 and Per2.","date":"2022","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35755440","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46539,"output_tokens":8895,"usd":0.136521},"stage2":{"model":"claude-opus-4-6","input_tokens":12921,"output_tokens":4407,"usd":0.26217},"total_usd":0.398691,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"CKIε phosphorylates PER2, recruiting the ubiquitin E3 ligase adapter β-TrCP to a specific phosphodegron site, leading to PER2 ubiquitination and 26S proteasome-mediated degradation; CKIε inhibition slows PER2 degradation and lengthens circadian period in Rat-1 cells.\",\n      \"method\": \"Cell-based PER2 degradation assay, dominant-negative β-TrCP overexpression, proteasome inhibitors, CKIε inhibition, circadian period measurement in synchronized cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal biochemical and cell-based methods in single study; replicated by subsequent work\",\n      \"pmids\": [\"15767683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Phosphorylation of PER2 at S662 by CKIδ stabilizes PER2 and increases Per2 transcription; the FASPS S662G mutation causes PER2 hypophosphorylation at this site and advanced sleep phase; CKIδ dosage modulates the S662 phenotype, demonstrating CKIδ regulates period through PER2 in vivo.\",\n      \"method\": \"Transgenic mice carrying human FASPS PER2 S662G mutation, in vitro CKI phosphorylation assay, behavioral circadian analysis, CKIδ dosage manipulation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro assay plus transgenic mouse model with human mutation; functional rescue experiments\",\n      \"pmids\": [\"17218255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"β-TrCP2 (as well as β-TrCP1) directly targets PER2 for degradation via a specific binding site (m2) on PER2; siRNA-mediated knockdown of β-TrCP1 and/or β-TrCP2 attenuates circadian oscillations in NIH3T3 cells.\",\n      \"method\": \"In vitro ubiquitin ligase assay, Luciferase-PER2 fusion stability assay, siRNA knockdown, real-time circadian reporter assay\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding site mapping plus functional cell-based assay with RNAi\",\n      \"pmids\": [\"18782782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Protein phosphatase 1 (PP1) dephosphorylates CKI-phosphorylated PER2, stabilizing it against ubiquitin-proteasome degradation; PER2 co-immunoprecipitates with PP1c in HEK-293 cells, mouse liver, and mouse brain; dominant-negative PP1c or PP1 inhibitors accelerate PER2 degradation and shorten PER2 half-life.\",\n      \"method\": \"Co-immunoprecipitation, Xenopus egg extract degradation assay, dominant-negative PP1c overexpression, PP1 inhibitor treatment, pulse-chase half-life measurement\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including reconstituted dephosphorylation assay and in vivo tissue co-IP\",\n      \"pmids\": [\"16813562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CK1δ/ε (including the CK1δ2 splice variant) serves as both the priming kinase and the downstream kinase for PER2; priming phosphorylation by CK1δ/ε initiates the phosphoswitch that stabilizes PER2 and lengthens circadian period; the CK1 C-terminal tail modulates period sensitivity to cellular signaling.\",\n      \"method\": \"Comprehensive biochemical and biophysical analysis of mPER2 priming phosphorylation in cells, mathematical phosphoswitch modeling, splice-variant comparison\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution plus mathematical modeling; multiple CK1 splice variants tested\",\n      \"pmids\": [\"29784789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Phosphorylation of PER2 at Ser478 by CK1 creates a β-TrCP phosphodegron; PER2-S478A knock-in mice show longer circadian period, accumulation of PER2 protein in nucleus and cytoplasm of liver, increased nuclear PER1/CRY1/CRY2, and perturbed three-phase decay and temperature compensation of circadian period in fibroblasts.\",\n      \"method\": \"PER2-S478A knock-in mouse generation, behavioral circadian analysis, western blot, PER2::LUC bioluminescence in mouse embryonic fibroblasts\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo knock-in mouse with multiple molecular and behavioral readouts\",\n      \"pmids\": [\"32354999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A conserved anion binding site in CK1 controls activation loop conformation and determines which sites on PER2 (stabilizing vs. destabilizing) are preferentially phosphorylated; period-altering CK1 mutations from humans to Drosophila differentially modulate this activation loop switch to elicit predictable changes in PER2 stability.\",\n      \"method\": \"Integrated experimental and computational studies, mutagenesis of CK1 anion binding site, measurement of PER2 phosphorylation and stability\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural/mechanistic biochemistry with mutagenesis across multiple species orthologs\",\n      \"pmids\": [\"32043967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PER2 activates transcription of BMAL1; CRY1, CRY2, and PER2 together upregulate BMAL1 expression while BMAL1-CLOCK heterodimers repress it, forming an interlocked feedback loop in the mammalian circadian clock.\",\n      \"method\": \"Promoter-reporter luciferase assay, genomic structure characterization of mBmal1\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based transcriptional assay; single lab but mechanistically clear\",\n      \"pmids\": [\"11798163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PER2 physically interacts with BMAL1 and CLOCK (but not CRY1/CRY2 with CLOCK); CRY proteins interact with BMAL1 at different domains than PER2; together PER2 and CRY proteins inhibit BMAL1-CLOCK transcriptional activation.\",\n      \"method\": \"Mammalian two-hybrid system, co-immunoprecipitation\",\n      \"journal\": \"BMC molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP and two-hybrid from single lab; replicated conceptually across field\",\n      \"pmids\": [\"18430226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PML (promyelocytic leukemia protein) physically interacts with PER2 and promotes PER2 nuclear localization in SCN neurons; loss of PML shifts PER2 to a predominantly perinuclear/cytoplasmic distribution and disrupts clock gene rhythms; SIRT1 deacetylates PML at K487 to regulate PML control of PER2 nuclear localization.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence localization, Pml-/- mouse analysis, SIRT1 deacetylation assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct interaction shown by co-IP, loss-of-function mouse with defined localization phenotype, PTM identified\",\n      \"pmids\": [\"22274616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CRY proteins are required for PER2 nuclear localization in SCN neurons; in the absence of CRY, PER2 is predominantly cytoplasmic and more mobile (measured by FRAP); virally expressed CRY1 or CRY2 relocalized PER2 to the nucleus and initiated SCN circadian rhythms; the C-terminal tail of CRY1 is necessary for PER2 nuclear relocalization.\",\n      \"method\": \"Confocal imaging of PER2::Venus reporter mice, viral vector expression of CRY variants, FRAP, translational switching to control CRY1 abundance\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — live imaging with FRAP plus CRY domain mutagenesis in intact SCN tissue\",\n      \"pmids\": [\"35046033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PER2 interacts with HIF-1α via co-immunoprecipitation and facilitates recruitment of HIF-1α to the hypoxia-response element (HRE) of the VEGF promoter; this requires that HIF-1α N803 is unhydroxylated; PER2 enhances HIF-1 transcriptional activity without changing HIF-1α protein or mRNA levels.\",\n      \"method\": \"Co-immunoprecipitation, chromatin immunoprecipitation/HRE binding assay, N803A point mutant of HIF-1α, deferoxamine treatment\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus functional ChIP-type assay; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"28963769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SIK3 promotes phosphorylation-dependent destabilization of PER2 protein; SIK3 knockdown increases PER2 protein levels while SIK3 overexpression decreases them; Sik3-deficient mice show elevated PER2 in fibroblasts and liver and lengthened circadian period.\",\n      \"method\": \"Sik3 knockout and knockdown in cells, western blot for PER2 protein levels, bioluminescence rhythm recording, liver fractionation\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO in vivo plus cell-based gain/loss-of-function; single lab\",\n      \"pmids\": [\"29227248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SIRT1 and PER2 form a reciprocal negative regulation loop: SIRT1 deficiency leads to enhanced H4K16 acetylation at the Per2 promoter causing Per2 overexpression; in turn, PER2 suppresses Sirt1 transcription by binding to the Sirt1 promoter at the Clock/Bmal1 site.\",\n      \"method\": \"Sirt1-deficient mouse model, ChIP assay for H4K16 acetylation at Per2 promoter, chromatin binding of PER2 at Sirt1 promoter, human hepatocyte validation\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP in vivo plus functional reciprocal regulation; replicated in human cells\",\n      \"pmids\": [\"27346580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIRT6 interacts with and deacetylates PER2, preventing its proteasomal degradation; loss of Sirt6 disrupts circadian phase.\",\n      \"method\": \"Co-immunoprecipitation, deacetylation assay, Sirt6-knockout cells, circadian phase analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus enzymatic deacetylation assay; single lab\",\n      \"pmids\": [\"30782483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Clock-Bmal1 recruits the Ddb1-Cullin-4 ubiquitin ligase to Per1 and Per2 gene loci; rhythmic H2B monoubiquitination at Per genes depends on Bmal1, Ddb1, and Cullin-4a; this chromatin mark facilitates subsequent recruitment of the Per repressor complex to Clock-Bmal1 on DNA.\",\n      \"method\": \"ChIP for H2B monoubiquitination, depletion of Ddb1-Cullin-4a, circadian reporter assay, Co-IP of Per complex with Clock-Bmal1\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple chromatin methods, functional depletion, mechanistic demonstration of licensing step\",\n      \"pmids\": [\"26323038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PER2 acts as a co-factor of CREB to facilitate assembly of the CREB/CRTC1/CBP transactivation complex on the CRE element of the Per1 gene regulatory region in response to light or forskolin; absence of PER2 abolishes CBP-CREB interaction, reduces histone H3 acetylation at the Per1 gene, and decreases RNA Pol II recruitment.\",\n      \"method\": \"In vitro and in vivo CREB/CRTC1/CBP interaction assays, ChIP for H3 acetylation and RNA Pol II, Per2-/- mouse light-stimulation experiments\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple co-IP and ChIP experiments plus in vivo validation; single lab\",\n      \"pmids\": [\"34741086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The PAS-B domain of mouse PER2 binds Fe(III) heme with 1:1 stoichiometry using His454 as an axial ligand; heme binding is pH-sensitive and shows faster dissociation kinetics than myoglobin, distinct from the PAS-A domain properties.\",\n      \"method\": \"Spectroscopic characterization (UV-Vis, CD), diethylpyrocarbonate treatment, H454A point mutant, heme dissociation kinetics\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical characterization with mutagenesis; single lab\",\n      \"pmids\": [\"20887817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Per2(Brdm1) mutant mice (with PAS domain deletion) show reduced expression of glutamate transporter Eaat1 in astrocytes, leading to decreased glutamate uptake, elevated extracellular glutamate, and increased alcohol consumption; acamprosate normalizes glutamate levels and alcohol intake in these mice.\",\n      \"method\": \"Per2 mutant mouse analysis, glutamate transporter expression and glutamate uptake assays, acamprosate pharmacological rescue, alcohol consumption measurement\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic mouse model with biochemical mechanism (transporter expression, glutamate levels) and pharmacological rescue; highly cited foundational paper\",\n      \"pmids\": [\"15608650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PER2 physically interacts with ERα (estrogen receptor-alpha); PER2 binding enhances ERα degradation, while Per2 suppression stabilizes ERα; PER2 overexpression in breast cancer cells causes growth inhibition, loss of clonogenic ability, and apoptosis; Per2 itself is estrogen-inducible suggesting a feedback loop.\",\n      \"method\": \"Co-immunoprecipitation, Per2 overexpression/knockdown, ERα stability (cycloheximide chase), colony formation and apoptosis assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP plus functional cell biology; single lab\",\n      \"pmids\": [\"17599055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"KSRP promotes decay of Per2 mRNA through direct RNA-protein interaction with the AU-rich element in the Per2 3' UTR; KSRP ablation increases Per2 expression and delays circadian phase of clock genes in liver, leading to reduced lipogenic gene expression.\",\n      \"method\": \"RNA-protein interaction assay, heterologous mRNA reporter with Per2 3' UTR, Ksrp-/- mice, primary hepatocyte culture, qRT-PCR\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA-protein interaction demonstrated plus in vivo genetic validation\",\n      \"pmids\": [\"25514904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PER2 binds to HSP90 through its PAS1 domain, reducing the interaction of HSP90 with IKKα/β; this promotes IKKα/β ubiquitination and inhibits IKK/NF-κB pathway activity, thereby suppressing PD-L1 expression in oral squamous cell carcinoma.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, CHX chase assay, PAS1 domain deletion mutant, IKK ubiquitination assay, in vivo xenograft model\",\n      \"journal\": \"Journal for immunotherapy of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — GST pull-down plus co-IP with domain mapping and functional in vivo validation; single lab\",\n      \"pmids\": [\"37914384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Per1 and Per2 are required for activation of Igf2 (an autocrine promoter of myoblast differentiation); Per1/Per2 depletion suppresses RNA Pol II recruitment, reduces dynamic histone modifications at the Igf2 promoter and enhancer, and disrupts promoter-enhancer interaction, thereby impairing myoblast differentiation and muscle regeneration.\",\n      \"method\": \"Per1/Per2 siRNA depletion in myoblasts, ChIP for histone modifications and RNA Pol II, chromatin conformation capture, in vivo muscle regeneration after cardiotoxin injury\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP, chromatin conformation, and in vivo regeneration with multiple orthogonal methods\",\n      \"pmids\": [\"34009269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TNF-α inhibits Per2 transcription in rheumatoid synovial cells through D-box binding proteins DBP, HLF, TEF (activators) and E4BP4 (repressor); mutation of D-box 1 and D-box 2 motifs in the Per2 promoter abolished TNF-α-mediated transcriptional inhibition.\",\n      \"method\": \"Site-directed mutagenesis of Per2 promoter D-box motifs, luciferase reporter assay, qRT-PCR in primary synovial cells\",\n      \"journal\": \"Scandinavian journal of rheumatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter mutagenesis plus reporter assay in primary human cells; single lab\",\n      \"pmids\": [\"23496259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A minimal upstream open reading frame (uORF) in the 5' UTR of Per2 mediates temperature-dependent translational upregulation of PER2 protein without affecting Per2 transcription; PI3K lies upstream of this uORF-mediated translation; genetic ablation of the Per2 uORF impairs entrainment of cells to physiological body temperature cycles and delays wound healing in vivo.\",\n      \"method\": \"Genetic uORF ablation (knock-in mice), ribosome profiling, PI3K inhibition, cell entrainment to temperature cycles, wound healing assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo knock-in plus ribosome profiling and functional rescue; multiple orthogonal methods\",\n      \"pmids\": [\"36882059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Egr1 binds directly to two Egr1-binding sites (EBS) in the Per2 promoter (positions -180 to -100) and mediates lithium-induced Per2 transcription; lithium activates the ERK1/2/Elk1 pathway to induce Egr1, which then drives Per2 expression; Egr1-/- mice show attenuated Per2 induction by lithium in frontal cortex.\",\n      \"method\": \"Serial promoter deletion reporter assays, EBS point mutation, EMSA, ChIP, Egr1 siRNA and Egr1-/- mouse\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — EMSA + ChIP + promoter mutagenesis + in vivo validation in Egr1-/- mouse\",\n      \"pmids\": [\"23816566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sevoflurane anesthesia reduces CLOCK binding to the E'-box in the Per2 promoter and decreases histone H4 acetylation at the proximal Per2 promoter region, suppressing Per2 expression in the SCN; this occurs independently of NAD+ levels in the SCN.\",\n      \"method\": \"ChIP with anti-acetylated histone H4 and anti-CLOCK antibodies, LC-MS for SCN NAD+ levels, in vitro SCN explant culture with Per2-dLuc reporter\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-based mechanism in vivo and in vitro SCN explant; single lab\",\n      \"pmids\": [\"24498074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PER2 regulates AKT activity; cells with downregulated PER2 show prolonged high-level AKT T308 phosphorylation after growth factor stimulation or DNA damage; PER2 knockdown also delays DNA damage-induced Chk2 activation and overrides DNA damage-induced apoptosis and cell cycle arrest.\",\n      \"method\": \"PER2 siRNA knockdown, western blot for p-AKT T308 and p-Chk2, DNA damage assays, apoptosis and cell cycle analysis\",\n      \"journal\": \"Biochemistry and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — siRNA loss-of-function with multiple signaling readouts; single lab\",\n      \"pmids\": [\"22905719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Per2 deficiency enhances Ucp2 gene expression in the liver; absence of Per2 causes elevated Clock expression which drives Ucp2 upregulation via a Clock-controlled PPARα signal transduction pathway, leading to decreased intracellular ATP and increased susceptibility to CCl4-induced hepatotoxicity.\",\n      \"method\": \"Per2-null mice, qRT-PCR and protein analysis of Ucp2/Clock/PPARα, ATP measurement, histological analysis of liver injury\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — in vivo genetic model with pathway dissection; single lab\",\n      \"pmids\": [\"19056852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PER2 periodically suppresses PCNA transcription by displacing the CLOCK-BMAL1 heterodimer from the PCNA promoter in a CRY1/2-dependent manner, thereby impeding oxaliplatin-induced DNA adduct repair in oral squamous cell carcinoma cells.\",\n      \"method\": \"Chromatin immunoprecipitation (pulldown) of CLOCK-BMAL1 from PCNA promoter, PER2 overexpression/knockdown, CRY1/2-dependent co-expression experiments, DNA adduct repair assays\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP-based promoter occupancy assay plus functional DNA repair readout; single lab\",\n      \"pmids\": [\"31728273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PER2-mediated ameloblast differentiation operates through the PPARγ/AKT1/β-catenin signaling axis; Per2 knockdown decreases PPARγ expression and AKT1 phosphorylation and alters β-catenin localization; overexpression of PPARγ partially rescues Per2 knockdown phenotypes.\",\n      \"method\": \"Per2 knockdown by RNAi in ameloblast-lineage cells (ALC), overexpression of PPARγ as rescue, western blot for pathway components, in vivo circadian disruption mouse model with PPARγ agonist rescue\",\n      \"journal\": \"International journal of oral science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — RNAi KD with pathway rescue in vitro and in vivo; single lab\",\n      \"pmids\": [\"34011974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Endogenous dopamine regulates the daily rhythm of PER2 expression in the dorsal striatum through daily activation of D2 (but not D1) dopamine receptors; depletion of striatal dopamine (6-OHDA or α-methyl-para-tyrosine) or D2 receptor blockade blunts the PER2 rhythm; timed D2 receptor activation restores and entrains PER2 rhythm in dopamine-depleted striatum.\",\n      \"method\": \"6-OHDA and AMPT dopamine depletion, receptor-specific pharmacology (raclopride D2 blockade, D1/D2 agonists), immunohistochemistry for PER2 in rat brain regions\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with multiple receptor-specific interventions and timed rescue; single lab\",\n      \"pmids\": [\"20962226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Estrogen directly affects the circadian clock in the uterus: 17β-estradiol (E2) applied to explanted uterus cultures shortens the period of PER2::LUC expression; this effect is attenuated by raloxifene (estrogen receptor antagonist), indicating estrogen acts via estrogen receptors to modulate PER2 rhythms in the uterus but not the SCN.\",\n      \"method\": \"PER2::LUC tissue explant culture from ovariectomized knockin mice, estrogen/raloxifene treatment, bioluminescence recording\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct tissue explant experiment with pharmacological receptor dissection; single lab\",\n      \"pmids\": [\"18728223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Per2 mutant mice lack food-anticipatory activity under restricted feeding conditions, while Per1 mutants and wild-type mice show normal food anticipation; peripheral phase shifts of clock-gene expression in response to timed food restriction are comparable across all genotypes, placing PER2 specifically in a central food-entrainable oscillator pathway but not peripheral feeding synchronization.\",\n      \"method\": \"Per2 and Per1 mutant mouse behavioral analysis (rest-activity, body temperature rhythms), clock-gene expression in SCN and peripheral tissues under restricted feeding\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in mouse model with specific behavioral and molecular readouts; independently consistent across multiple organs\",\n      \"pmids\": [\"17055980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Per2 mutation in mice (PAS domain deletion) is associated with increased cyclooxygenase-1 (but not COX-2) protein levels in aorta, decreased NO production, and altered prostaglandin production, leading to impaired endothelium-dependent relaxation; endothelial dysfunction is not associated with hypertension or dyslipidemia.\",\n      \"method\": \"Organ chamber studies with aortic rings, Western blot for COX-1/COX-2/eNOS, pharmacological dissection with indomethacin, Per2 mutant mouse model\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — genetic mouse model with ex vivo vascular function assays and protein expression analysis; single lab\",\n      \"pmids\": [\"17404161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Per2 mutation in MEFs increases resistance to ROS-induced cytotoxicity; this is paralleled by altered Bcl-2 expression; elevated survival and altered NADH/NAD+ ratio in mutant cells is reversed by reintroduction of wild-type Per2; clock-synchronized cells display time-dependent sensitivity to paraquat.\",\n      \"method\": \"Per2 mutant MEFs, ROS (paraquat) treatment, cell viability assay, Bcl-2 expression, NADH/NAD+ measurement, wild-type Per2 rescue\",\n      \"journal\": \"Frontiers in neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — genetic loss-of-function with rescue experiment; multiple biochemical readouts; single lab\",\n      \"pmids\": [\"25628599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PER2 enhances HIF-1α transcriptional activity to induce cell cycle genes Ccnb2, Cdc20, and Espl1 in pituitary cells; PER2 upregulation in jet-lagged mice accelerates pituitary adenoma growth, while Per2 loss protects against estrogen-induced pituitary adenoma; SR8278 (which decreases PER2 expression) has anti-tumor effects.\",\n      \"method\": \"RNA-seq, in vivo jet-lag and estrogen-induced pituitary adenoma models, PER2 overexpression/KO, HIF-1α ChIP, luciferase reporter for HIF-1α target genes\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model plus mechanistic ChIP; multiple orthogonal approaches; single lab\",\n      \"pmids\": [\"37215573\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PER2 is a core negative-limb component of the mammalian circadian transcription-translation feedback loop that physically interacts with BMAL1, CLOCK, and CRY proteins to repress CLOCK-BMAL1-driven transcription; its abundance is primarily controlled by a CK1δ/ε-driven multisite phosphoswitch in which priming phosphorylation stabilizes PER2 (extending period) while phosphorylation at the Ser478 phosphodegron recruits β-TrCP E3 ubiquitin ligase for proteasomal degradation, a process counteracted by PP1-mediated dephosphorylation and modulated by SIRT1/SIRT6-mediated deacetylation; nuclear entry of PER2 requires CRY proteins and is facilitated by PML, while a 5' uORF enables temperature-dependent translational upregulation; beyond timekeeping, PER2 functions as a transcriptional co-factor (with CREB/CRTC1/CBP on the Per1 CRE, and with HIF-1α at hypoxia-response elements), regulates glutamatergic, dopaminergic, and estrogen receptor signaling, suppresses IKK/NF-κB and AKT pathways, and controls fatty acid metabolism, thereby linking the circadian clock to cancer suppression, metabolic regulation, and cardiovascular function.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PER2 is a core component of the mammalian circadian transcription–translation feedback loop that represses CLOCK–BMAL1-driven transcription while simultaneously activating Bmal1 expression, thereby sustaining oscillatory gene expression across tissues. PER2 protein abundance is governed by a CK1δ/ε-dependent phosphoswitch: priming phosphorylation at S662 stabilizes PER2 and lengthens circadian period, whereas phosphorylation at S478 creates a β-TrCP phosphodegron that targets PER2 for ubiquitin–proteasome degradation — a balance modulated by PP1 dephosphorylation, SIRT6-mediated deacetylation, and a 5′ uORF that confers temperature-dependent translational control [PMID:17218255, PMID:32354999, PMID:15767683, PMID:16813562, PMID:30782483, PMID:36882059]. Nuclear entry of PER2 requires CRY proteins and is facilitated by PML, and once nuclear, PER2 acts as a transcriptional co-factor — assembling the CREB/CRTC1/CBP complex at the Per1 CRE, enhancing HIF-1α recruitment to hypoxia-response elements, and displacing CLOCK–BMAL1 from target promoters such as PCNA [PMID:35046033, PMID:22274616, PMID:34741086, PMID:28963769, PMID:31728273]. Beyond timekeeping, PER2 links the clock to metabolism, vascular function, and tumor suppression by regulating glutamate transporter expression, estrogen receptor α stability, IKK/NF-κB signaling via competitive HSP90 binding, and AKT pathway activity [PMID:15608650, PMID:17599055, PMID:37914384, PMID:22905719].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing PER2 as part of an interlocked feedback loop — not merely a repressor — resolved how Bmal1 transcription is sustained, showing PER2 positively drives Bmal1 expression while CLOCK–BMAL1 represses it.\",\n      \"evidence\": \"Promoter-reporter luciferase assays measuring Bmal1 transcription in the presence of PER2, CRY1, and CRY2\",\n      \"pmids\": [\"11798163\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which PER2 activates Bmal1 transcription (direct DNA binding vs. cofactor role) was not resolved\", \"In vivo validation not provided\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that Per2 mutation reduces astrocytic glutamate transporter Eaat1 expression and increases alcohol intake established PER2 as a regulator of glutamatergic signaling and addiction-relevant behavior.\",\n      \"evidence\": \"Per2(Brdm1) mutant mice with glutamate uptake assays and pharmacological rescue by acamprosate\",\n      \"pmids\": [\"15608650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PER2 directly regulates Eaat1 transcription or acts indirectly was not determined\", \"Mechanism linking PAS domain deletion to transporter downregulation unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identifying the CKIε→β-TrCP→proteasome degradation axis for PER2 defined the primary mechanism controlling PER2 protein clearance and linked kinase activity to circadian period length.\",\n      \"evidence\": \"Dominant-negative β-TrCP, CKIε inhibition, proteasome inhibitors, and period measurement in Rat-1 cells\",\n      \"pmids\": [\"15767683\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphodegron residue not yet mapped\", \"Relative contributions of CKIε vs. CKIδ to PER2 degradation in vivo unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing that PP1 dephosphorylates CKI-phosphorylated PER2 to stabilize it established a kinase–phosphatase balance as the tuning mechanism for PER2 half-life and, by extension, circadian period.\",\n      \"evidence\": \"Co-IP of PER2 with PP1c in HEK-293 cells, mouse liver and brain; dominant-negative PP1c and inhibitor treatment accelerated PER2 degradation\",\n      \"pmids\": [\"16813562\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which PP1 regulatory subunit targets PP1 to PER2 was not identified\", \"Whether PP1 acts on the stabilizing or degron phosphosites was unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Per2 mutant mice specifically lacking food-anticipatory activity revealed PER2 as an essential component of a food-entrainable oscillator distinct from the SCN master clock.\",\n      \"evidence\": \"Behavioral and molecular analysis of Per2 vs. Per1 mutant mice under restricted feeding\",\n      \"pmids\": [\"17055980\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Anatomical locus of the food-entrainable oscillator not identified\", \"Molecular mechanism by which PER2 contributes to food anticipation unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The FASPS S662G mutation in PER2 established the phosphoswitch model: CKIδ-mediated phosphorylation at S662 stabilizes PER2, and loss of this phosphorylation shortens period and causes familial advanced sleep phase syndrome in humans.\",\n      \"evidence\": \"Transgenic mice carrying human PER2 S662G, in vitro CKI phosphorylation, CKIδ dosage manipulation\",\n      \"pmids\": [\"17218255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How S662 phosphorylation mechanistically opposes degron-directed phosphorylation was not resolved\", \"Structural basis of the phosphoswitch unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"PER2 interaction with ERα and promotion of its degradation linked the circadian clock to estrogen signaling and breast cancer cell growth control.\",\n      \"evidence\": \"Co-IP of PER2–ERα, cycloheximide chase showing enhanced ERα degradation upon PER2 overexpression, growth inhibition and apoptosis in breast cancer cells\",\n      \"pmids\": [\"17599055\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PER2 recruits a specific E3 ligase to ERα was not determined\", \"Single lab; not independently confirmed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Mapping PER2 physical interactions with BMAL1 and CLOCK via distinct domains (separate from CRY interaction domains) defined the architecture of the repressive complex on E-box elements.\",\n      \"evidence\": \"Mammalian two-hybrid and co-immunoprecipitation in HEK-293 cells\",\n      \"pmids\": [\"18430226\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry and dynamics of the repressive complex in living cells unresolved\", \"Single interaction methodology per pair\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that PER2's PAS-B domain binds Fe(III) heme with 1:1 stoichiometry raised the possibility that PER2 senses metabolic/redox state, though functional consequences remained undefined.\",\n      \"evidence\": \"UV-Vis/CD spectroscopy, H454A mutagenesis, heme dissociation kinetics\",\n      \"pmids\": [\"20887817\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological role of heme binding in circadian regulation not established\", \"In vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"PML was identified as a nuclear import facilitator for PER2, linking PML body dynamics and SIRT1-mediated deacetylation of PML to circadian clock function in SCN neurons.\",\n      \"evidence\": \"Co-IP of PER2–PML, immunofluorescence in SCN, Pml−/− mice showing cytoplasmic PER2 redistribution, SIRT1 deacetylation of PML-K487\",\n      \"pmids\": [\"22274616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PML acts as a direct nuclear import chaperone or indirectly through PML bodies was not distinguished\", \"Relative contribution of PML vs. CRY-dependent import not quantified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovery that CLOCK–BMAL1 recruits the DDB1–CUL4 ubiquitin ligase to Per loci for rhythmic H2B monoubiquitination established a chromatin licensing step required for PER2 repressor complex recruitment to its own promoter.\",\n      \"evidence\": \"ChIP for H2Bub at Per genes, DDB1-CUL4a depletion, circadian reporter assays\",\n      \"pmids\": [\"26323038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether H2Bub is specifically required for PER2 or for the entire PER–CRY complex was not separated\", \"Mechanism linking monoubiquitination to repressor docking not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Unified phosphoswitch model: CK1δ/ε serves as both priming kinase and downstream kinase on PER2, with CK1 splice variants and C-terminal tail modulating period sensitivity — resolving the paradox of how a single kinase family produces both stabilizing and destabilizing phosphorylation.\",\n      \"evidence\": \"Biochemical reconstitution of PER2 priming phosphorylation, mathematical modeling, CK1 splice-variant comparison\",\n      \"pmids\": [\"29784789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full phosphosite map of endogenous PER2 in vivo not available\", \"Role of other kinases (e.g., SIK3) in the phosphoswitch hierarchy unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The PER2-S478A knock-in mouse definitively identified S478 as the β-TrCP phosphodegron site in vivo, showing that blocking this single phosphorylation lengthens period, accumulates PER2 in both compartments, and disrupts temperature compensation.\",\n      \"evidence\": \"Knock-in mouse behavioral and molecular analysis, PER2::LUC fibroblast bioluminescence\",\n      \"pmids\": [\"32354999\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether S478 phosphorylation is the sole degradation trigger or acts in concert with other degron sites\", \"Structural basis of β-TrCP recognition of phospho-S478 peptide not determined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"An anion binding site in CK1 controls activation loop conformation and determines which PER2 phosphosites (stabilizing vs. destabilizing) are preferentially targeted, providing a structural explanation for period-altering CK1 mutations across species.\",\n      \"evidence\": \"CK1 anion-binding-site mutagenesis, PER2 phosphorylation/stability measurements, cross-species comparison\",\n      \"pmids\": [\"32043967\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether intracellular anion concentrations physiologically modulate this switch is unknown\", \"No full crystal structure of CK1 bound to PER2 peptide\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"PER2 was shown to function as a transcriptional co-activator at the Per1 CRE by assembling the CREB/CRTC1/CBP complex, establishing that PER2 has a direct positive transcriptional role beyond its canonical repressor function.\",\n      \"evidence\": \"In vitro/in vivo CREB–CRTC1–CBP interaction assays, ChIP for H3 acetylation and RNA Pol II at Per1, light-stimulation in Per2−/− mice\",\n      \"pmids\": [\"34741086\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PER2 directly contacts CRE DNA or acts solely as a scaffold was not determined\", \"Generalizability of co-activator role beyond Per1 not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"CRY proteins were established as essential gatekeepers for PER2 nuclear entry in SCN neurons, with the CRY1 C-terminal tail required for relocalization — clarifying why CRY loss abolishes circadian rhythms even when PER2 is present.\",\n      \"evidence\": \"Confocal imaging and FRAP of PER2::Venus in Cry-null SCN, viral CRY1/CRY2 rescue, CRY1 tail deletion\",\n      \"pmids\": [\"35046033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CRY masks a PER2 nuclear export signal or actively drives import is unknown\", \"Relative contributions of CRY1 vs. CRY2 to PER2 import quantitatively unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A 5′ uORF in Per2 mRNA was identified as a temperature-sensing translational switch controlled by PI3K, providing a mechanism for peripheral temperature entrainment independent of transcriptional regulation.\",\n      \"evidence\": \"uORF knock-in ablation mice, ribosome profiling, PI3K inhibition, temperature-cycle entrainment assays, wound-healing assay\",\n      \"pmids\": [\"36882059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the PI3K-regulated factor that modulates uORF bypass unknown\", \"Whether this mechanism operates in SCN neurons not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"PER2 was shown to suppress IKK/NF-κB signaling by competitively binding HSP90 through its PAS1 domain, promoting IKKα/β ubiquitination and reducing PD-L1 expression — extending PER2's tumor-suppressive functions to immune evasion.\",\n      \"evidence\": \"GST pull-down, co-IP, PAS1 deletion mutant, IKK ubiquitination assay, xenograft model in oral squamous cell carcinoma\",\n      \"pmids\": [\"37914384\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PER2–HSP90 interaction is circadian-gated not tested\", \"Single cancer type; generalizability to other tissues unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include: the full structural basis of the CK1–PER2 phosphoswitch complex, how PER2 coordinates its dual repressor and co-activator transcriptional roles genome-wide, the identity of the food-entrainable oscillator circuit in which PER2 is essential, and whether heme binding to the PAS-B domain has a physiological signaling role.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of full-length PER2 in complex with CK1 or CRY\", \"Genome-wide map of PER2 co-activator vs. repressor targets unavailable\", \"Anatomical and molecular identity of PER2-dependent food-entrainable oscillator undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [7, 8, 16, 29]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [19, 21, 27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 9, 10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [0, 1, 4, 5, 6, 7, 8]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 15, 16, 22]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [21, 27, 30]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2, 3, 5]}\n    ],\n    \"complexes\": [\n      \"PER–CRY repressor complex\",\n      \"CLOCK–BMAL1–PER2 complex\"\n    ],\n    \"partners\": [\n      \"CRY1\",\n      \"CRY2\",\n      \"BMAL1\",\n      \"CLOCK\",\n      \"CSNK1D\",\n      \"CSNK1E\",\n      \"BTRC\",\n      \"PML\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}